Form 4: Agilon Health Director Karen McLoughlin Acquires 25,000 Shares

Agilon Health director Karen McLoughlin purchased 25,000 shares of common stock at a weighted average price of $2.2034 per share on December 13, 2024.

Summary

• On December 13, 2024, Karen McLoughlin, a director at Agilon Health, Inc., acquired 25,000 shares of the company's common stock.
• The shares were purchased at a weighted average price of $2.2034 per share.
• The transactions occurred in multiple trades with prices ranging from $2.175 to $2.215 per share.
• Following the transaction, McLoughlin's total holdings include 73,166 shares, which includes restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but this is a routine transaction and not a major event.

Positives

• A director's purchase of shares can be seen as a positive signal of confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders when they trade company stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• SEC Form 4 filings are a standard practice for publicly traded companies in the United States.
• The level of detail provided in this filing is consistent with regulatory requirements.
• Similar filings are made by directors and officers of other publicly traded companies when they buy or sell shares.

Stakeholder Impact

• The share purchase may have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Agilon Health, insider trading, share purchase, common stock, director, Karen McLoughlin, AGL